Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Emmalene J, Bartlett"'
Autor:
Ruth A. Karron, Alexander C. Schmidt, Peter L. Collins, Brian R. Murphy, Anne Schaap-Nutt, Emmalene J. Bartlett
Publikováno v:
New Generation Vaccines ISBN: 9780429130090
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32f8fafa8f1900536d3d6e3073882cf2
https://doi.org/10.3109/9781420060744-62
https://doi.org/10.3109/9781420060744-62
Autor:
Margaret A. Scull, Alexander C. Schmidt, Raymond J. Pickles, Rachael M. Liesman, Anne Schaap-Nutt, Peter L. Collins, Emmalene J. Bartlett
Publikováno v:
Virology. 433:320-328
Human parainfluenza viruses (PIVs) cause acute respiratory illness in children, the elderly, and immunocompromised patients. PIV3 is a common cause of bronchiolitis and pneumonia, whereas PIV1 and 2 are frequent causes of upper respiratory tract illn
Autor:
Janice Esker, Peter L. Collins, Jim Boonyaratanakornkit, Ann-Marie Cruz, Mario H. Skiadopoulos, Alexander C. Schmidt, Adam Castaño, Emmalene J. Bartlett, Brian R. Murphy
Publikováno v:
Vaccine. 28:767-779
A novel recombinant human parainfluenza virus type 1 (rHPIV1), rHPIV1-C+P, in which the overlapping open reading frames of the C and P genes were separated in order to introduce mutations into the C gene without affecting P, was generated. Infectious
Autor:
Emerito Amaro-Carambot, Brian R. Murphy, Emmalene J. Bartlett, Jim Boonyaratanakornkit, Alexander C. Schmidt, Peter L. Collins
Publikováno v:
Journal of Virology. 83:1892-1910
Human parainfluenza virus type 1 (HPIV1) is an important respiratory pathogen in children and the most common cause of viral croup. We performed a microarray-based analysis of gene expression kinetics to examine how wild-type (wt) HPIV1 infection alt
Autor:
Janice Esker, Murphy Brian R, Henrick Schomacker, Peter L. Collins, Alexander C. Schmidt, Raymond J. Pickles, Sonja R. Surman, Adam Castaño, Emmalene J. Bartlett, Jim Boonyaratanakornkit, Ann Marie Cruz, Margaret Hennessey
Publikováno v:
Journal of Virology. 82:8965-8977
Recombinant human parainfluenza virus type 1 (rHPIV1) was modified to create rHPIV1-P(C−), a virus in which expression of the C proteins (C′, C, Y1, and Y2) was silenced without affecting the amino acid sequence of the P protein. Infectious rHPIV
Autor:
Mohammad Yazid Abdad, Cassandra M. James, Azita Rezazadeh Vind, Hege K. Jacobsen, Emmalene J. Bartlett, Philip A. Stumbles, Josephine P. Mansfield
Publikováno v:
Vaccine. 25:1856-1867
Vaccines are urgently needed to elicit immunity to different influenza virus strains. DNA vaccines can elicit partial protective immunity, however their efficacy requires improvement. We assessed the capacity of individual type I IFN multigene family
Autor:
William Van Cleve, Mario H. Skiadopoulos, Joseph Bekisz, Sonja R. Surman, Peter L. Collins, Kathryn C. Zoon, Brian R. Murphy, Emerito Amaro-Carambot, Emmalene J. Bartlett
Publikováno v:
Virology. 352(1):61-73
Recombinant human parainfluenza virus type 1 (HPIV1) and mutants containing point and deletion (Δ) mutations in the P/C gene (r-C Δ10–15 HN T553A , r-C R84G , r-C F170S and r-C Δ170 ), which have previously been evaluated as HPIV1 vaccine candid
Optimization of Naked DNA Delivery for Interferon Subtype Immunotherapy in Cytomegalovirus Infection
Autor:
Josephine P. Mansfield, Emmalene J. Bartlett, Eva N. Mowe, Cassandra M. James, Vanessa S. Cull
Publikováno v:
Biological Procedures Online, Vol 5, Iss 1, Pp 43-52 (2003)
Biological Procedures
Biological Procedures
Type I interferon (IFN) gene therapy modulates the immune response leading to inflammatory heart disease following cytomegalovirus (CMV) infection in a murine model of post-viral myocarditis. Efficacy of different immunisation protocols for the IFN c
Publikováno v:
Gene Therapy. 9:1369-1378
Viral DNA vaccines encoding the glycoprotein B (gB) of cytomegalovirus provide partial protective immunity upon challenge with infectious virus. Although it is known that type I IFN can stimulate the adaptive immune response, their direct use in vacc
Publikováno v:
Immunology. 106:428-437
Type I interferons (IFNs) are produced early in response to viral infection and modulate adaptive immunity. Previously we demonstrated localized protection against murine cytomegalovirus (MCMV) infection in IFN DNA-inoculated mice. Here we examine th